Welcome to our dedicated page for Enovix Corporation SEC filings (Ticker: ENVX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Enovix Corporation (ENVX) SEC filings page on Stock Titan provides access to the company’s official U.S. regulatory documents, along with AI-powered summaries to help interpret complex disclosures. As a Nasdaq-listed battery technology company focused on advanced lithium-ion cells and 100% active silicon-anode architectures, Enovix uses its SEC reports to describe financial performance, capital structure, risk factors and material events.
Through this page, you can review annual reports on Form 10-K and quarterly reports on Form 10-Q, which discuss Enovix’s business model, battery technology, manufacturing footprint in regions such as Malaysia and South Korea, and markets including smartphones, smart eyewear, IoT, industrial and defense applications. Our AI tools highlight key sections, such as revenue trends, operating expenses, liquidity, and the Risk Factors and MD&A discussions referenced in the company’s press releases.
You can also follow current reports on Form 8-K, where Enovix has disclosed items such as quarterly financial results, a warrant dividend distribution, authorization of a share repurchase plan, and the issuance of 4.75% Convertible Senior Notes due 2030 with related capped call transactions. These filings explain terms of the notes, conversion conditions, redemption provisions and the intended use of proceeds, including potential acquisitions in the battery ecosystem.
In addition, this page surfaces registration statements, prospectus supplements and related exhibits that describe the warrant program (ENVXW), share issuance mechanics and legal opinions, as well as any future Form 4 insider transaction reports when available. AI-generated overviews help clarify technical language, summarize covenant and event-of-default provisions, and point out changes in capital structure or share count. Together, these tools allow investors to navigate Enovix’s regulatory history more efficiently while still relying on the underlying SEC documents as the authoritative source.
Enovix Corporation is a global battery company focused on designing, developing, manufacturing and commercializing advanced lithium-ion batteries using a proprietary 100% active silicon-anode architecture. Its AI-1™ platform targets smartphones, smart eyewear, defense, industrial and emerging edge-AI devices that require higher energy density in tight spaces.
The company has shifted from a broad, standard-cell strategy to deeper vertical programs with a smaller set of large OEM and ODM customers. Manufacturing has been consolidated into Fab2 in Malaysia and facilities in South Korea, supported by R&D centers in India and the U.S. A recent independent test showed the AI-1™ smartphone battery reached 935 Wh/L volumetric energy density.
Enovix highlights substantial risks: scaling a new and complex manufacturing process, achieving targeted throughput and yields, controlling raw material and production costs, and maintaining key third‑party manufacturing and supply relationships. It also notes a history of losses, a need for additional capital, customer concentration in certain sectors, global trade and geopolitical exposure, and the possibility that products under development may not reach commercial scale or expected performance.
Enovix Corporation reported strong top-line growth but continued losses, and expanded its share repurchase capacity. For full year 2025, revenue rose to
The company still posted a 2025 GAAP net loss of
Enovix Corp President and CEO Rajendra K. Talluri reported a tax-related share disposition tied to restricted stock units (RSUs). On
After this withholding, Talluri directly owned 2,202,787 shares, which include 1,494,734 shares issuable upon settlement of RSUs and 95,551 vested performance RSUs (PRSUs). For the PRSUs, 50% are scheduled to be released on
Enovix Corp Chief Accounting Officer Kristina Truong reported a tax-withholding disposition of 1,116 shares of common stock at $5.92 per share tied to RSU vesting. After this transaction, she holds 191,549 shares, including 139,724 RSUs and 4,978 vested PRSUs with future release dates.
Enovix Corp former Chief Operating Officer Ajay Marathe reported a tax-withholding disposition of 7,352 shares of common stock at $5.92 per share, tied to vesting of restricted stock units. After this withholding, he directly holds 313,893 shares. A separate disclosure notes cancellation of 596,596 RSUs, including 33,170 vested performance RSUs, with half scheduled for release on March 2, 2026 and the remainder on March 1, 2027.
Enovix Corp’s Chief Accounting Officer Kristina Truong reported a small share disposition related to equity compensation. On February 10, 2026, 278 shares of common stock were withheld at
After this tax-withholding transaction, Truong beneficially owned 192,665 shares of Enovix common stock. This total includes 141,639 shares tied to unvested RSUs and 4,978 vested performance RSUs, with half of those PRSUs scheduled to be released on March 2, 2026 and the remainder on March 1, 2027.
Enovix Corporation’s Chief Legal Officer, Arthi Chakravarthy, reported a routine tax-related share withholding tied to equity compensation. On 02/08/2026, 939 shares of Enovix common stock were withheld at a price of $6.38 per share to cover tax obligations from vesting restricted stock units (RSUs).
After this transaction, Chakravarthy beneficially owns 407,077 shares, including 276,946 shares issuable upon vesting and settlement of RSUs and 20,786 vested performance RSUs (PRSUs). Half of the PRSUs are scheduled to be released on March 2, 2026, with the remaining half on March 1, 2027.
Enovix Corp Chief Operating Officer Ajay Marathe reported a tax-related share withholding tied to equity compensation. On 02/08/2026, 1,493 shares of common stock were withheld at $6.38 per share to satisfy tax obligations from vesting restricted stock units.
After this transaction, he beneficially owns 917,841 shares, including 610,480 shares issuable upon vesting and settlement of RSUs and 33,170 vested performance RSUs. The performance RSUs are scheduled to be released 50% on March 2, 2026 and 50% on March 1, 2027, with each PRSU representing one share upon settlement.
Enovix Corp President and CEO Rajendra K. Talluri reported a routine share withholding tied to equity compensation. On February 8, 2026, 4,301 shares of Enovix common stock were withheld at
After this transaction, Talluri beneficially owned 2,220,437 shares, including 1,528,067 shares issuable upon settlement of RSUs and 95,551 vested performance RSUs. Half of these performance RSUs are scheduled for release on
Enovix Corporation’s Chief Legal Officer, Arthi Chakravarthy, reported an automatic share withholding tied to equity compensation. On 01/24/2026, 2,443 shares of Enovix common stock were withheld at $7.53 per share to cover tax obligations triggered by the vesting of restricted stock units.
After this tax withholding, Chakravarthy beneficially owned 408,016 shares. This amount includes 278,713 shares issuable upon future RSU vesting and 20,786 vested performance RSUs, with 50% scheduled for release on March 2, 2026 and the remaining 50% on March 1, 2027.